Andrei Iagaru

Clinical Trials

• Recruiting 3D Dynamic Contrast-Enhanced Ultrasound Imaging in Predicting Treatment Response in Patients With Liver Metastases From Colon Cancer
• Not Recruiting Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer
• Not Recruiting F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
• Not Recruiting A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
• Recruiting 18F FPPRGD2 Positron Emission Tomography/Computed Tomography in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
• Recruiting Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
• Recruiting PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases
• Recruiting Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy
• Not Recruiting Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer
• Not Recruiting Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System
• Not Recruiting Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
• Not Recruiting Correlation of PET-CT Studies With Serum Protein Analysis
• Recruiting Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
• Not Recruiting Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT